Does Sanofi have a patient assistance program?
Sanofi Patient Connection® is a program (the “Program”) to help you get access to the medications and resources you need at no cost. Patient Assistance Connection is part of the Program that provides select Sanofi prescription medications and vaccines, at no cost, if you meet certain eligibility requirements.
What is a patient support program?
A patient assistance or support programs (PAPs or PSPs) exist to get you timely access to medication and to help you stay on track of your therapy. Being diagnosed with a complex disease or condition may come with unexpected financial burden and a need to better understand treatment options and next steps.
How can I get free Lovenox?
Enrollment forms can be obtained by accessing the website or by calling (888) 632-8607. Participants seeking Lovenox free of charge are required to complete a Patient Assistance Application. Signature from both the prescribing physician and patient are required.
What is Sanofi Aventis phone number?
800-981-2491Prescription Customer Care For general information about our products and programs in the U.S., call 800-981-2491, fill out the form using the link below or check our Frequently Asked Questions.
Why do pharmaceutical companies offer patient assistance programs?
They increase demand, allow companies to charge higher prices, and provide public-relations benefits. Assistance programs are an especially attractive proposition for firms that sell particularly costly drugs. Faced with high out-of-pocket costs, some patients may decide against taking an expensive medication.
Why have a patient support program?
Patient Support Programs (PSPs) are an umbrella term to describe initiatives led by pharmaceutical companies to improve access, usage, and adherence to prescription drugs. These programs can have a financial component, support clinical investments, focus purely on education, or a combination.
How much is Lovenox a month?
Your monthly Lovenox cost savings if eligibleStrengthAvg. monthly price at a US pharmacyNiceRx monthly price150mg/ml 12 syringes$1,450.00$49.0030mg/0.3ml 12 syringes$320.00$49.0040mg/0.4ml 12 syringes$425.00$49.0060mg/0.6ml 12 syringes$599.00$49.003 more rows
How much is a box of Lovenox?
The cost for Lovenox injectable solution (30 mg/0.3 mL) is around $77 for a supply of 3 milliliters, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
How much does Lovenox shots cost?
The average Lovenox price is around $410.49 for 10, 10ML of 40MG/0.4ML Solution Prefilled Syringe.
Where is Sanofi located in the US?
Bridgewater, New JerseyHeadquartered in Bridgewater, New Jersey, Sanofi in the United States employs more than 12,500 professionals throughout the country.
Is Sanofi a big company?
Sanofi (US$36.6BN -2%) French multinational pharmaceutical giant, Sanofi, is the ninth largest pharmaceutical company in the world by revenue. Sanofi provides healthcare solutions to over 100 countries worldwide and has three core focuses: speciality care, vaccines, and general medicines.
What does Sanofi Genzyme do?
Genzyme focuses on six areas of medicine relating to lysosomal storage diseases, renal disease, orthopedics, transplant and immune diseases, oncology, genetics and diagnostics. The first orphan-drug for Genzyme that FDA approved was Ceredase, a drug for treating Gaucher disease.
Is there a generic version of Lovenox?
How is enoxaparin marketed? Enoxaparin is marketed under the brand name Lovenox and as a generic drug under the name enoxaparin sodium for injection. 4.
How much does enoxaparin cost without insurance?
How much does Enoxaparin Sodium cost without insurance? On average, uninsured customers can expect to pay $239.23 for Enoxaparin Sodium. However, $18.99 for 10, 10ml of 40mg/0.4ml Syringe is all you pay per prescription fill with a SingleCare Enoxaparin Sodium coupon.
Is Lovenox covered by Medicare Part D?
Yes. 100% of Medicare prescription drug plans cover this drug.
Who manufactures Lovenox?
No sooner did Sandoz begin shipments of the generic version, Sanofi-Aventis, manufacturer of Lovenox, filed a lawsuit to prevent the approval of the generic. Last year, Lovenox recorded $4.57 billion in sales for Sanofi-Aventis, according to IMS Health.